NCT06593678 Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection
| NCT ID | NCT06593678 |
| Status | Active, Not Recruiting |
| Phase | — |
| Sponsor | Instituto de Investigación Sanitaria Aragón |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2024-08-30 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2024-08-30 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study, titled: Telerehabilitation in Oncology Patients: Optimization of Prehabilitation and Rehabilitation Post-Colorectal Resection. Is a randomized clinical trial conducted at the Royo Villanova Hospital in Zaragoza, Spain. It aims to evaluate the effectiveness of a tele-rehabilitation program in enhancing functional capacity and quality of life for patients undergoing colorectal cancer surgery. Colorectal cancer (CRC) is a highly prevalent malignant tumor that significantly impacts global health and patients\' quality of life, particularly after surgery. Prehabilitation and postoperative rehabilitation are crucial for recovery, and telerehabilitation offers a promising alternative to improve outcomes in CRC patients.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 80 years. * Participants who understand Spanish. * Patients scheduled for colorectal cancer surgery at Royo Villanova Hospital, Zaragoza, Spain. * Patients attending the first consultation in the General and Digestive Surgery Section under the supervision of Dr. Blas, head of surgery at Royo Villanova Hospital, Zaragoza, Spain. * Participants with functional independence that allows them to perform walking and pulmonary function tests. * Patients with a preoperative assessment score of I, II, or III on the American Society of Anesthesiologists (ASA) scale. * Participants who agree to participate and sign the informed consent form. Exclusion Criteria: * Patients older than 80 years. * Patients with a preoperative ASA score of IV. * Patients with any injury, pathology, or inflammatory processes that make it impossible to practice exercise. * Patients with central and/or peripheral neurological diseases that prevent them from following the rehabilitation program. * Patients with unstable cardiac comorbidities such as arrhythmias, high blood pressure, angina pectoris, or other conditions that contraindicate moderate-intensity training. * Patients diagnosed with a psychiatric disorder as confirmed by a psychiatrist. * Patients without access to mobile internet or a computer with internet at home. * Patients who score ≤ 24 on the Mini-Mental State Examination (MMSE). * Individuals who are unable to follow oral and written instructions in Spanish. * Patients who refuse to participate in the study or who have not signed the informed consent form.
Contact & Investigator
Sandra Calvo, PhD
PRINCIPAL INVESTIGATOR
Universidad de Zaragoza
Frequently Asked Questions
Who can join the NCT06593678 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06593678 currently recruiting?
NCT06593678 is currently listed as "Active, Not Recruiting" and is not actively enrolling. Check ClinicalTrials.gov for the latest status updates.
Where is the NCT06593678 trial being conducted?
This trial is being conducted at Zaragoza, Spain.
Who is sponsoring the NCT06593678 clinical trial?
NCT06593678 is sponsored by Instituto de Investigación Sanitaria Aragón. The principal investigator is Sandra Calvo, PhD at Universidad de Zaragoza. The trial plans to enroll 54 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.